Performance of the first commercial dual resistance assay, AmpliSens Mycoplasma genitalium-ML/FQ-Resist-FL, for detection of potential macrolide and quinolone resistance-associated mutations and prevalence of M. genitalium resistance mutations in St. Petersburg, Russia

OBJECTIVES: Antimicrobial resistance in Mycoplasma genitalium (MG) is a poorly surveyed and controlled global health concern. We evaluated the first commercial dual resistance assay, AmpliSens M. genitalium-ML/FQ-Resist-FL assay, for detection of potential macrolide and quinolone resistance-associat...

Descripción completa

Detalles Bibliográficos
Autores principales: Shipitsyna, Elena, Khusnutdinova, Tatiana, Budilovskaya, Olga, Shedko, Elizaveta, Goloveshkina, Elena, Khayrullina, Guzel, Krysanova, Anna, Shalepo, Kira, Savicheva, Alevtina, Unemo, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176367/
https://www.ncbi.nlm.nih.gov/pubmed/35710533
http://dx.doi.org/10.1136/sextrans-2021-055249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176367/
https://www.ncbi.nlm.nih.gov/pubmed/35710533
http://dx.doi.org/10.1136/sextrans-2021-055249

Ejemplares similares